Status:
COMPLETED
Assesment of the Metabolomic Signature in COVID-19 Patients
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Metabolomics is the analysis of small molecules in a biological sample (cells, tissues or biological fluids). It can potentially detect very sensitively any change related to a pathology or exposure t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patient over 18 years of age
- affiliated to a social security scheme
- consultant in the emergency department and/or being hospitalized for suspected SARS CoV infection
- confirmation, after medical examination, of the need for a biological examination (this will negate the need for additional venipuncture)
- Exclusion criteria:
- Patient who do not meet inclusion criteria
- Person subject to a guardianship order
- Opposition to the use of the data or samples (withdrawal of non-opposition) / Sponsor's or investigator's decision
Exclusion
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04497272
Start Date
August 7 2020
End Date
July 31 2022
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de nice
Nice, Alpes-Maritimes, France, 06001